NEW YORK, May 30, 2017 -- On May 18, LifeSci Advisors’ Paul Yook, General Partner, LifeSci Venture Partners, moderated the opening panel at MedCity INVEST, a healthcare investing conference held this year in Chicago, IL.
Led by Yook, the “What’s Hot in Biopharma Investing?” panel included Jack Gilbert, Co-Founder and Scientific Advisor, Gusto Global; Director, Microbiome Center, University of Chicago, Ed Mathers, Partner, NEA and Ilan Zipkin, Ph.D., Senior Investment Director, Takeda Ventures, Inc. The discussion touched on topics ranging from trends in the industry to advice on pitching VC investors.
The two-day INVEST Conference drew nearly 400 business, healthcare and technology executives and investors from around the country to network and learn about trends and opportunities in the industry.
“It’s important to hear perspectives from both the VC and laboratory side on where the industry is going,” said Paul Yook. “The INVEST audience wants to know what’s coming next in the biopharma industry and discussions like this are crucial for staying ahead of the curve.”
Yook established and manages LifeSci Venture Partners, a newly launched healthcare venture capital fund affiliated with LifeSci Partners, and LifeSci Index Partners, an SEC-registered investment advisor and index provider to the BioShares exchange traded funds. Prior to joining LifeSci in June 2014, Yook worked as a healthcare hedge fund portfolio manager and equity research analyst at Galleon Management. He began his Wall Street career in healthcare investment banking at UBS Securities and at Goldman, Sachs & Co. where he was involved in numerous IPOs, secondary offerings and M&A transactions for healthcare companies ranging from small, emerging biotechnology companies to large, multinational pharmaceutical companies. He earned a B.S.E. in Economics from the Wharton School and a B.A. in Biochemistry from the College of Arts and Sciences at the University of Pennsylvania.
MedCity INVEST is presented by MedCity News, producer of unique innovation-focused events across the healthcare ecosystem, and MHIN (Mid-America Healthcare Investors Network), a nonprofit organization composed of more than 40 venture capital firms. The INVEST conference is the premier national healthcare investing conference based in the Midwest. For well over a decade, INVEST has united active investors with corporate business development executives to syndicate investment opportunities with promising start-ups from the biopharmaceutical, diagnostics, medical devices, digital health/health IT and health services sectors.
About LifeSci Advisors:
LifeSci Advisors, LLC (www.lifesciadvisors.com) is a unique investor relations consultancy founded to provide companies in the life sciences a comprehensive solution to investor communications and outreach. With a local presence in New York, Boston, Chicago, Philadelphia, London, Geneva and Tel Aviv, the firm provides the highest quality service for its clients through its deep sector specialization. Our roster of PhDs enables us to better understand our clients' R&D, regulatory, and commercial strategy, and our team of financial services, investor relations, and public relations specialists help our clients effectively communicate to the marketplace. This combination of life sciences, financial services, and investor relations competencies allows us to provide a valuable and unique service offering to our clients.
About LifeSci Partners:
LifeSci Partners (www.lifescipartners.com) is the leading provider of comprehensive consulting services in the areas of investor relations, corporate communications, public relations and capital markets advisory. Combining deep domain expertise in the life sciences and decades of experience in capital markets and public relations, we deliver unparalleled services to life sciences companies globally. LifeSci Partners has a physical presence in New York, Chicago, London, Geneva and Israel.
For further information, please contact: Michael Rice Founding Partner LifeSci Advisors, LLC (646) 597-6979 [email protected]


Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Washington Post Publisher Will Lewis Steps Down After Layoffs
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge 



